{"id":"https://openalex.org/W4240263227","doi":"https://doi.org/10.1002/ddr.430050303","title":"Fluradoline (HP 494), a centrally acting analgesic with antidepressant properties: Antidepressant pharmacology","display_name":"Fluradoline (HP 494), a centrally acting analgesic with antidepressant properties: Antidepressant pharmacology","publication_year":1985,"publication_date":"1985-01-01","ids":{"openalex":"https://openalex.org/W4240263227","doi":"https://doi.org/10.1002/ddr.430050303"},"language":"en","primary_location":{"id":"doi:10.1002/ddr.430050303","doi":"https://doi.org/10.1002/ddr.430050303","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ddr.430050303","pdf_url":null,"source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087974983","display_name":"Theodore C. Spaulding","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Spaulding","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"S. Fielding","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Fielding","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064824320","display_name":"Michael L. Cornfeldt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Cornfeldt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049869783","display_name":"Jeffrey C. Wilker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Wilker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112523872","display_name":"Daniel B. Ellis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. B. Ellis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113872562","display_name":"W. J. JUN. NOVICK","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. J. Novick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5103350006","display_name":"Helen H. Ong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. H. Ong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3980,"currency":"USD","value_usd":3980},"apc_paid":null,"fwci":0.7879,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.7459388,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"3","first_page":"207","last_page":"215"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antidepressant-effects","display_name":"antidepressant effects","score":0.9580000042915344},{"id":"https://openalex.org/keywords/analgesic-effect","display_name":"analgesic effect","score":0.6179999709129333},{"id":"https://openalex.org/keywords/monoamine-reuptake-inhibition","display_name":"monoamine reuptake inhibition","score":0.8090000152587891},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":0.9169999957084656},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.9940000176429749}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.755866527557373},{"id":"https://openalex.org/C2779145073","wikidata":"https://www.wikidata.org/wiki/Q58396","display_name":"Imipramine","level":3,"score":0.7532123327255249},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.7079001069068909},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.6340500116348267},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5825643539428711},{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.4641275405883789},{"id":"https://openalex.org/C2779657639","wikidata":"https://www.wikidata.org/wiki/Q908843","display_name":"Tricyclic antidepressant","level":4,"score":0.4423930048942566},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24587461352348328},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2386321723461151},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.10031914710998535},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/ddr.430050303","doi":"https://doi.org/10.1002/ddr.430050303","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ddr.430050303","pdf_url":null,"source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W1931517214","https://openalex.org/W1986676027","https://openalex.org/W2093070202","https://openalex.org/W4240767275","https://openalex.org/W4245195685"],"related_works":["https://openalex.org/W2043442353","https://openalex.org/W2087554537","https://openalex.org/W2055288131","https://openalex.org/W2002410482","https://openalex.org/W2785768060","https://openalex.org/W7145397004","https://openalex.org/W2092148098","https://openalex.org/W2090885776","https://openalex.org/W2113922703","https://openalex.org/W2078959870"],"abstract_inverted_index":{"Abstract":[0],"Fluradoline":[1],"(HP":[2],"494),":[3],"a":[4,112,143],"tricyclic":[5],"dibenz":[6],"(b,":[7],"f)":[8],"oxepine":[9],"derivative":[10],"with":[11],"an":[12],"analgesic":[13,139],"profile,":[14,140],"was":[15,24,68,106,110],"tested":[16],"for":[17,48,96],"antidepressant":[18,145],"activity.":[19],"After":[20],"oral":[21],"administration,":[22],"fluradoline":[23,43,109],"twice":[25],"as":[26,28],"potent":[27],"imipramine":[29],"and":[30,74,101,126],"similar":[31],"in":[32,36,62,80,99,102,128,135],"potency":[33],"to":[34,84,137],"desmethylimipramine":[35],"blocking":[37],"tetrabenazine\u2010induced":[38],"ptosis.":[39],"Like":[40],"standard":[41],"antidepressants,":[42],"selectively":[44],"increased":[45],"response":[46],"rates":[47,61],"electrical":[49],"stimulation":[50],"of":[51,77,123,152,154],"the":[52,87,117,121,138,150],"median":[53],"forebrain":[54],"bundle":[55],"using":[56],"internal":[57],"capsule\u2010lesioned":[58],"rats.":[59],"Response":[60],"nonlesioned":[63],"rats":[64],"were":[65],"unaffected.":[66],"There":[67],"partial":[69],"protection":[70],"against":[71],"yohimbine":[72],"toxicity":[73],"no":[75],"potentiation":[76],"5\u2010hydroxytryptophan\u2010induced":[78],"seizures":[79],"mice.":[81],"When":[82],"administered":[83],"squirrel":[85],"monkeys,":[86],"EEG":[88],"profile":[89,146],"from":[90],"cortically\u2010placed":[91],"electrodes":[92],"resembled":[93],"that":[94,108,134],"found":[95],"imipramine.":[97],"Using":[98],"vivo":[100],"vitro":[103],"techniques,":[104],"it":[105],"shown":[107],"not":[111],"monoamine":[113],"oxidase":[114],"inhibitor;":[115],"however,":[116],"compound":[118],"did":[119],"block":[120],"reuptake":[122],"norepinephrine,":[124],"serotonin":[125],"dopamine":[127],"brain":[129],"homogenates.":[130],"These":[131],"results":[132],"suggest":[133],"addition":[136],"there":[141],"is":[142],"concomitant":[144],"which":[147],"may":[148],"enhance":[149],"spectrum":[151],"activity":[153],"fluradoline.":[155]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}